How to buy Hologic shares

Own Hologic shares in just a few minutes.

hologic logo

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Hologic, Inc (HOLX) is a leading medical instruments & supplies business with stocks listed in the US. It opened the day at US$63.31 after a previous close of US$63.17. During the day the price has varied from a low of USD63.05 to a high of USD64.46. The latest price was USD64.02 (25 minute delay). Hologic is listed on the NASDAQ. All prices are listed in US Dollars.

How to buy shares in Hologic

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Hologic. Find the share by name or ticker symbol: HOLX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Hologic reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$60.72, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Hologic, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Hologic. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Hologic share price

Use our graph to track the performance of HOLX stocks over time.

Hologic shares at a glance

Information last updated 2021-06-22.
OpenUS$63.31
HighUS$64.46
LowUS$63.05
CloseUS$64.02
Previous closeUS$63.17
Change US$0.85
Change % 1.3456%
Volume 1,996,818
Information last updated 2021-06-17.
52-week rangeUS$53.02 - US$85
50-day moving average US$63.3943
200-day moving average US$72.0947
Target priceUS$82.92
PE ratio 8.6309
Dividend yield N/A (0%)
Earnings per share (TTM) US$7.282

Compare share trading platforms to buy stock

Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro (US, EU stock trading)
US$0
US$10 per month if there’s been no login for 12 months
0.50%
Global shares, US shares, ETFs
Zero brokerage share trading on US stocks with trades as low as $50.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
US$0
$50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
US$9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
US$0
No
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Hologic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Hologic price performance over time

Historical closes compared with the last close of $64.02

1 week (2021-06-16) 3.44%
1 month (2021-05-21) 2.56%
3 months (2021-03-23) -11.98%
6 months (2020-12-23) -14.71%
1 year (2020-06-23) 15.35%
2 years (2019-06-21) 30.47%
3 years (2018-06-22) 58.23%
5 years (2016-06-23) 79.73%

Is Hologic under- or over-valued?

Valuing Hologic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hologic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Hologic's P/E ratio

Hologic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Hologic shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Hologic's PEG ratio

Hologic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6262. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Hologic's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Hologic's EBITDA

Hologic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$2.9 billion.

The EBITDA is a measure of a Hologic's overall financial performance and is widely used to measure a its profitability.

Hologic financials

Revenue TTM US$5.3 billion
Operating margin TTM 47.33%
Gross profit TTM US$2.5 billion
Return on assets TTM 21.16%
Return on equity TTM 64.65%
Profit margin 35.87%
Book value 14.81
Market capitalisation US$16.1 billion

TTM: trailing 12 months

Shorting Hologic shares

There are currently 6.0 million Hologic shares held short by investors – that's known as Hologic's "short interest". This figure is 8.3% up from 5.5 million last month.

There are a few different ways that this level of interest in shorting Hologic shares can be evaluated.

Hologic's "short interest ratio" (SIR)

Hologic's "short interest ratio" (SIR) is the quantity of Hologic shares currently shorted divided by the average quantity of Hologic shares traded daily (recently around 3.0 million). Hologic's SIR currently stands at 1.96. In other words for every 100,000 Hologic shares traded daily on the market, roughly 1960 shares are currently held short.

However Hologic's short interest can also be evaluated against the total number of Hologic shares, or, against the total number of tradable Hologic shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Hologic's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Hologic shares in existence, roughly 20 shares are currently held short) or 0.0234% of the tradable shares (for every 100,000 tradable Hologic shares, roughly 23 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Hologic.

Find out more about how you can short Hologic stock.

Hologic's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Hologic.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Hologic's total ESG risk score

Total ESG risk: 28.6

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Hologic's overall score of 28.6 (as at 12/31/2018) is nothing to write home about – landing it in it in the 58th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Hologic is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Hologic's environmental score

Environmental score: 2.95/100

Hologic's environmental score of 2.95 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Hologic is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Hologic's social score

Social score: 11.28/100

Hologic's social score of 11.28 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Hologic is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Hologic's governance score

Governance score: 8.88/100

Hologic's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Hologic is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Hologic's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Hologic scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Hologic has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Hologic, Inc was last rated for ESG on: 2019-01-01.

Total ESG score 28.6
Total ESG percentile 58.02
Environmental score 2.95
Environmental score percentile 1
Social score 11.28
Social score percentile 1
Governance score 8.88
Governance score percentile 1
Level of controversy 2

Hologic share dividends

We're not expecting Hologic to pay a dividend over the next 12 months.

Have Hologic's shares ever split?

Hologic's shares were split on a 2:1 basis on 2 April 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Hologic shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Hologic shares which in turn could have impacted Hologic's share price.

Hologic share price volatility

Over the last 12 months, Hologic's shares have ranged in value from as little as US$53.02 up to US$85. A popular way to gauge a stock's volatility is its "beta".

HOLX.US volatility(beta: 1.17)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hologic's is 1.1707. This would suggest that Hologic's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Hologic overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform